Cirrhotic Cardiomyopathy
Conditions
Interventions
Cohort A: Regional Etiological Retrospective Comparison Group (Multicenter Retrospective Cohort):None
Cohort B: Special Retrospective Follow-up Group with TIPS Procedure:None
Cohort C: Prospective 2D-STI Longitudinal Follow-up Group:None
Sponsors
Jiangsu Province Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with a clinical diagnosis of liver cirrhosis. 2.Those with complete clinical medical records (retrospective group) or who voluntarily sign informed consent forms and can cooperate with follow-up visits (prospective group). 3.Those from whom clear echocardiographic images eligible for 2D-STI analysis can be obtained.
Exclusion criteria
Exclusion criteria: 1.Combined with severe organic heart diseases (such as severe valvular heart disease, congenital heart disease, cardiomyopathy, etc.). 2.Suffering from other malignant tumors except primary liver cancer. 3.Patients with missing clinical data or unqualified image quality for strain analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Etiological composition and baseline clinical characteristics of liver cirrhosis;Left Ventricular Global Longitudinal Strain (GLS) and Standard Echocardiographic Parameters;Detection Rate of Cirrhotic Cardiomyopathy (CCM) and Clinical Stratification;6-month Cumulative Mortality and Incidence of Decompensation Events;Etiological Composition and Severity Scores (MELD/Child-Pugh);6-month Readmission Rate Related to Cirrhosis Complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum NT-proBNP and Troponin Levels; | — |
Countries
China
Contacts
Public ContactXiaoyan Wang
Jiangsu Province Hospital
Outcome results
None listed